Eisai Co.

Eisai’s Marketing Authorization Application for Potential Insomnia Disorder Treatment Lemborexant Submitted in Japan

New Delhi, March 08, 2019: Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for…

6 years ago

Eisai Enters Into Agreement to Support International Ngo Association for Aid and Relief, Japan’s Activities in Sudan

New Delhi, February 28, 2019: Eisai Co., Ltd. has entered an agreement to support the international non-governmental organization Association for Aid…

6 years ago

AbbVie and Eisai Announce the Launch of HUMIRA Pen, an Auto-Injector Formulation for Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA

Tokyo, June 24, 2018: AbbVie GK, Eisai Co., Ltd. and Eisai’s subsidiary for gastrointestinal diseases EA Pharma Co., Ltd.announced that the…

6 years ago